Entinostat is a narrow-spectrum HDAC inhibitor of class I HDAC that has been shown to possess neuroprotective functions in brain ischemia and intracerebral hemorrhage (Mota et al., 2020; Bonsack and Sukumari-Ramesh, 2021). The gene discussed is HDAC9; the disease is intracerebral hemorrhage.